The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective, randomized, multicenter, double-blinded, placebo-controlled phase III trial of the HER2/neu peptide GP2 + GM-CSF versus bacteriostatic saline/WFI placebo as adjuvant therapy after any trastuzumab-based therapy in HER2-positive women with operable breast cancer.
 
Snehal Patel
Employment - Greenwich LifeSciences
Leadership - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
Patents, Royalties, Other Intellectual Property - Westport Bio
 
David McWilliams
Leadership - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
 
Christine T Fischette
Leadership - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
 
Jaye Thompson
Employment - Greenwich LifeSciences
Leadership - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
 
F. Joseph Daugherty
Employment - Greenwich LifeSciences
Leadership - Greenwich LifeSciences
Stock and Other Ownership Interests - Greenwich LifeSciences
 
C. Kent Osborne
Consulting or Advisory Role - Genentech; Tolmar
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Other Relationship - Lilly
 
Mothaffar F. Rimawi
Consulting or Advisory Role - Daiichi Sankyo; Genentech; Macrogenics; Seagen
Research Funding - Pfizer (Inst)